USA Noninvasive Prenatal Diagnostics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the USA Noninvasive Prenatal Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Noninvasive Prenatal Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Noninvasive Prenatal Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • TrovaGene

    • Labcorp

    • Berry Genomics

    • Natera

    • Ariosa Diagnostics

    • BGI Diagnosis

    • NIPD Genetics

    • LifeCodexx

    • Ravgen

    • Premaitha Health

    • Illumina

    • Ariosa Diagnostics

    • Quest Diagnostics

    By Type:

    • Services

    • Instrument

    By End-User:

    • Hospital

    • Personal

    • Other

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Noninvasive Prenatal Diagnostics Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Services from 2016 to 2027

      • 1.3.2 USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Instrument from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Hospital from 2016 to 2027

      • 1.4.2 USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Personal from 2016 to 2027

      • 1.4.3 USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Other from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Noninvasive Prenatal Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Noninvasive Prenatal Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Noninvasive Prenatal Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Noninvasive Prenatal Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Noninvasive Prenatal Diagnostics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Noninvasive Prenatal Diagnostics by Major Types

      • 3.4.1 Market Size and Growth Rate of Services

      • 3.4.2 Market Size and Growth Rate of Instrument

    4 Segmentation of Noninvasive Prenatal Diagnostics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Noninvasive Prenatal Diagnostics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Noninvasive Prenatal Diagnostics in Hospital

      • 4.4.2 Market Size and Growth Rate of Noninvasive Prenatal Diagnostics in Personal

      • 4.4.3 Market Size and Growth Rate of Noninvasive Prenatal Diagnostics in Other

    5 Market Analysis by Regions

    • 5.1 USA Noninvasive Prenatal Diagnostics Production Analysis by Regions

    • 5.2 USA Noninvasive Prenatal Diagnostics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Noninvasive Prenatal Diagnostics Landscape Analysis

    • 6.1 West USA Noninvasive Prenatal Diagnostics Landscape Analysis by Major Types

    • 6.2 West USA Noninvasive Prenatal Diagnostics Landscape Analysis by Major End-Users

    7 South USA Noninvasive Prenatal Diagnostics Landscape Analysis

    • 7.1 South USA Noninvasive Prenatal Diagnostics Landscape Analysis by Major Types

    • 7.2 South USA Noninvasive Prenatal Diagnostics Landscape Analysis by Major End-Users

    8 Middle West USA Noninvasive Prenatal Diagnostics Landscape Analysis

    • 8.1 Middle West USA Noninvasive Prenatal Diagnostics Landscape Analysis by Major Types

    • 8.2 Middle West USA Noninvasive Prenatal Diagnostics Landscape Analysis by Major End-Users

    9 Northeast USA Noninvasive Prenatal Diagnostics Landscape Analysis

    • 9.1 Northeast USA Noninvasive Prenatal Diagnostics Landscape Analysis by Major Types

    • 9.2 Northeast USA Noninvasive Prenatal Diagnostics Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 TrovaGene

        • 10.1.1 TrovaGene Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Labcorp

        • 10.2.1 Labcorp Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Berry Genomics

        • 10.3.1 Berry Genomics Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 Natera

        • 10.4.1 Natera Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Ariosa Diagnostics

        • 10.5.1 Ariosa Diagnostics Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 BGI Diagnosis

        • 10.6.1 BGI Diagnosis Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 NIPD Genetics

        • 10.7.1 NIPD Genetics Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 LifeCodexx

        • 10.8.1 LifeCodexx Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Ravgen

        • 10.9.1 Ravgen Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

      • 10.10 Premaitha Health

        • 10.10.1 Premaitha Health Company Profile and Recent Development

        • 10.10.2 Market Performance

        • 10.10.3 Product and Service Introduction

      • 10.11 Illumina

        • 10.11.1 Illumina Company Profile and Recent Development

        • 10.11.2 Market Performance

        • 10.11.3 Product and Service Introduction

      • 10.12 Ariosa Diagnostics

        • 10.12.1 Ariosa Diagnostics Company Profile and Recent Development

        • 10.12.2 Market Performance

        • 10.12.3 Product and Service Introduction

      • 10.13 Quest Diagnostics

        • 10.13.1 Quest Diagnostics Company Profile and Recent Development

        • 10.13.2 Market Performance

        • 10.13.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Services from 2016 to 2027

    • Figure USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Instrument from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Hospital from 2016 to 2027

    • Figure USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Personal from 2016 to 2027

    • Figure USA Noninvasive Prenatal Diagnostics Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Noninvasive Prenatal Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Noninvasive Prenatal Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Noninvasive Prenatal Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Noninvasive Prenatal Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Noninvasive Prenatal Diagnostics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Noninvasive Prenatal Diagnostics

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Noninvasive Prenatal Diagnostics by Different Types from 2016 to 2027

    • Table Consumption Share of Noninvasive Prenatal Diagnostics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Services

    • Figure Market Size and Growth Rate of Instrument

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Noninvasive Prenatal Diagnostics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Noninvasive Prenatal Diagnostics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Personal

    • Figure Market Size and Growth Rate of Other

    • Table USA Noninvasive Prenatal Diagnostics Production by Regions

    • Table USA Noninvasive Prenatal Diagnostics Production Share by Regions

    • Figure USA Noninvasive Prenatal Diagnostics Production Share by Regions in 2016

    • Figure USA Noninvasive Prenatal Diagnostics Production Share by Regions in 2021

    • Figure USA Noninvasive Prenatal Diagnostics Production Share by Regions in 2027

    • Table USA Noninvasive Prenatal Diagnostics Consumption by Regions

    • Table USA Noninvasive Prenatal Diagnostics Consumption Share by Regions

    • Figure USA Noninvasive Prenatal Diagnostics Consumption Share by Regions in 2016

    • Figure USA Noninvasive Prenatal Diagnostics Consumption Share by Regions in 2021

    • Figure USA Noninvasive Prenatal Diagnostics Consumption Share by Regions in 2027

    • Table West USA Noninvasive Prenatal Diagnostics Consumption by Types from 2016 to 2027

    • Table West USA Noninvasive Prenatal Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure West USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2016

    • Figure West USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2021

    • Figure West USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2027

    • Table West USA Noninvasive Prenatal Diagnostics Consumption by End-Users from 2016 to 2027

    • Table West USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2016

    • Figure West USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2021

    • Figure West USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2027

    • Table South USA Noninvasive Prenatal Diagnostics Consumption by Types from 2016 to 2027

    • Table South USA Noninvasive Prenatal Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure South USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2016

    • Figure South USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2021

    • Figure South USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2027

    • Table South USA Noninvasive Prenatal Diagnostics Consumption by End-Users from 2016 to 2027

    • Table South USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2016

    • Figure South USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2021

    • Figure South USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2027

    • Table Middle West USA Noninvasive Prenatal Diagnostics Consumption by Types from 2016 to 2027

    • Table Middle West USA Noninvasive Prenatal Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2016

    • Figure Middle West USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2021

    • Figure Middle West USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2027

    • Table Middle West USA Noninvasive Prenatal Diagnostics Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2016

    • Figure Middle West USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2021

    • Figure Middle West USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2027

    • Table Northeast USA Noninvasive Prenatal Diagnostics Consumption by Types from 2016 to 2027

    • Table Northeast USA Noninvasive Prenatal Diagnostics Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2016

    • Figure Northeast USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2021

    • Figure Northeast USA Noninvasive Prenatal Diagnostics Consumption Share by Types in 2027

    • Table Northeast USA Noninvasive Prenatal Diagnostics Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2016

    • Figure Northeast USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2021

    • Figure Northeast USA Noninvasive Prenatal Diagnostics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of TrovaGene

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TrovaGene

    • Figure Sales and Growth Rate Analysis of TrovaGene

    • Figure Revenue and Market Share Analysis of TrovaGene

    • Table Product and Service Introduction of TrovaGene

    • Table Company Profile and Development Status of Labcorp

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Labcorp

    • Figure Sales and Growth Rate Analysis of Labcorp

    • Figure Revenue and Market Share Analysis of Labcorp

    • Table Product and Service Introduction of Labcorp

    • Table Company Profile and Development Status of Berry Genomics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Berry Genomics

    • Figure Sales and Growth Rate Analysis of Berry Genomics

    • Figure Revenue and Market Share Analysis of Berry Genomics

    • Table Product and Service Introduction of Berry Genomics

    • Table Company Profile and Development Status of Natera

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Natera

    • Figure Sales and Growth Rate Analysis of Natera

    • Figure Revenue and Market Share Analysis of Natera

    • Table Product and Service Introduction of Natera

    • Table Company Profile and Development Status of Ariosa Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ariosa Diagnostics

    • Figure Sales and Growth Rate Analysis of Ariosa Diagnostics

    • Figure Revenue and Market Share Analysis of Ariosa Diagnostics

    • Table Product and Service Introduction of Ariosa Diagnostics

    • Table Company Profile and Development Status of BGI Diagnosis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of BGI Diagnosis

    • Figure Sales and Growth Rate Analysis of BGI Diagnosis

    • Figure Revenue and Market Share Analysis of BGI Diagnosis

    • Table Product and Service Introduction of BGI Diagnosis

    • Table Company Profile and Development Status of NIPD Genetics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NIPD Genetics

    • Figure Sales and Growth Rate Analysis of NIPD Genetics

    • Figure Revenue and Market Share Analysis of NIPD Genetics

    • Table Product and Service Introduction of NIPD Genetics

    • Table Company Profile and Development Status of LifeCodexx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LifeCodexx

    • Figure Sales and Growth Rate Analysis of LifeCodexx

    • Figure Revenue and Market Share Analysis of LifeCodexx

    • Table Product and Service Introduction of LifeCodexx

    • Table Company Profile and Development Status of Ravgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ravgen

    • Figure Sales and Growth Rate Analysis of Ravgen

    • Figure Revenue and Market Share Analysis of Ravgen

    • Table Product and Service Introduction of Ravgen

    • Table Company Profile and Development Status of Premaitha Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Premaitha Health

    • Figure Sales and Growth Rate Analysis of Premaitha Health

    • Figure Revenue and Market Share Analysis of Premaitha Health

    • Table Product and Service Introduction of Premaitha Health

    • Table Company Profile and Development Status of Illumina

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Illumina

    • Figure Sales and Growth Rate Analysis of Illumina

    • Figure Revenue and Market Share Analysis of Illumina

    • Table Product and Service Introduction of Illumina

    • Table Company Profile and Development Status of Ariosa Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ariosa Diagnostics

    • Figure Sales and Growth Rate Analysis of Ariosa Diagnostics

    • Figure Revenue and Market Share Analysis of Ariosa Diagnostics

    • Table Product and Service Introduction of Ariosa Diagnostics

    • Table Company Profile and Development Status of Quest Diagnostics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quest Diagnostics

    • Figure Sales and Growth Rate Analysis of Quest Diagnostics

    • Figure Revenue and Market Share Analysis of Quest Diagnostics

    • Table Product and Service Introduction of Quest Diagnostics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.